LediHep 90/400 mg Tablet
Available Dosages
| SKU | 2168 |
|---|---|
| Generic For | Hepcinat |
| Strength | 90/400mg |
| Manufacturer | Hetero Labs Ltd |
| Active Ingredient | Ledipasvir 90mg & Sofosbuvir 400mg |
| Pack Size | Qty | Price Per Pill or Unit | Price | Cart | |
|---|---|---|---|---|---|
| 28 Tablet/s | US$ 8.75 | US$ 245.0043%US$ 430.00 | |||
|
|||||
| 56 Tablet/s | US$ 8.75 | US$ 490.0043%US$ 860.00 | |||
|
|||||
LediHep 90/400 mg Tablet – Affordable Hepcinat Alternative
Ledihep 90/400 mg tablet is a treatment for hepatitis C. The antiviral tablets are formulated to prevent the hepatitis C virus from multiplying in an affected individual’s body. It is a single pill with a combination of two antiviral agents, namely ledipasvir and Sofosbuvir, both these ingredients are combined to treat HCV viral infection of the liver by strengthening the immune system. Hence, a stronger immune system is ready to fight the infection and assist in the fast recovery of the liver. HCV or hepatitis C virus attacks the liver and causes inflammation. In most cases, the immune system is unable to fight the infection on its own, which ultimately leads to permanent inflammation of the liver and cause cirrhosis. The condition interferes with liver function and increases the risk of liver cancer. Doctors may prescribe this antiviral medication with another one called Ribavirin so that infection does not relapse. Patients undergoing liver transplant can also use Ledihep tablets to stop the recurring of the infection.
The combination ledihep tablet comes in the form of a tablet that is meant to taken once daily. It is meant to either with or without food with an adequate amount of water. Antacids like aluminum and magnesium should not be consumed for a couple of hours after taking the medication. Generally, it is taken regularly preferable every morning for twelve weeks, and it is suggested that you do not miss even a single dose. Those suffering from any other kind of liver or kidney problems, or those who are on dialysis should not take include this antiviral drug in their routine.
The side effects may vary from one person to another and can be common to the severe ones. Also, some of the unwanted effects may depend on the patient’s health and condition. The commonly reported side effects associated with Ledihep 90/400 mg are anemia, headache, irritation, insomnia, fatigue, cough, nausea, fatigue, and pain in muscles. Some other adverse effects of the combination drug include loss of appetite, dizziness, and concentration problem. It is not advisable for ladies to conceive during the treatment, as it can lead to major health defects in the newborn baby. Signs of an allergic reaction such as rash, hives, peeling skin, wheezing, trouble breathing, unusual hoarseness, swelling of the mouth, tongue, or throat. Signs of liver problems like tiredness, upset stomach, light-colored stools, dark urine, not hungry, or yellow skin or eyes.
Ledihep 90/400 mg combination ledipasvir and Sofosbuvir have been approved for the treatment of hepatitis C infection in adults. The treatment aim is to stop the growth of the virus and prevent multiplication and associated complications. Depending on individual symptoms, standard therapies, including ribavirin, can be used to treat the infection. The use of Ledihep90/400 mg is welcomed by most of the doctor and health care professionals is highly effective and less toxic, which make this treatment successful and harmless. The antiviral drug act as an inhibitor that can block the multiplication of certain microorganisms, which allows easy passage to a stable virologic response and complete healing.
What is Ledipasvir 90mg & Sofosbuvir 400mg and what condition does it treat?
Ledipasvir 90mg & Sofosbuvir 400mg, marketed as LediHep 90/400 mg Tablet, is a direct-acting antiviral combination medication used to treat chronic hepatitis C virus (HCV) infection. This antiviral therapy combines two potent ingredients that work together to eliminate the virus from your body. Ledipasvir is an NS5A inhibitor while Sofosbuvir is a nucleotide analogue NS5B polymerase inhibitor. Together, they target different stages of the hepatitis C replication cycle, making this combination highly effective against multiple HCV genotypes, particularly genotypes 1, 4, 5, and 6, helping patients achieve sustained virologic response and potential cure.
How does Ledipasvir 90mg & Sofosbuvir 400mg work in the body?
LediHep 90/400 mg Tablet works by attacking the hepatitis C virus through a dual-action mechanism. Sofosbuvir converts into an active form that blocks the NS5B polymerase enzyme, which the virus needs to copy its genetic material and multiply. Ledipasvir targets the NS5A protein, essential for viral replication and assembly of new virus particles. By simultaneously disrupting these two critical processes, this antiviral combination prevents HCV from reproducing and spreading to healthy liver cells. This dual mechanism allows the body's immune system to clear the existing virus, leading to sustained virologic response in most patients within 8 to 24 weeks of treatment.
How long does LediHep 90/400 mg Tablet take to work?
LediHep 90/400 mg Tablet begins working immediately after your first dose, with Ledipasvir and Sofosbuvir rapidly reaching therapeutic levels in your bloodstream. However, measurable viral load reduction typically becomes evident within 2 to 4 weeks of starting this hepatitis C treatment. Complete viral clearance usually requires a full course of 8, 12, or 24 weeks depending on your HCV genotype, treatment history, and liver condition. Your healthcare provider will monitor your viral levels through blood tests during therapy. Most patients achieve sustained virologic response—meaning undetectable virus levels 12 weeks after completing treatment—which indicates successful hepatitis C cure.
When and how should I take LediHep 90/400 mg Tablet?
Take one LediHep 90/400 mg Tablet once daily, preferably at the same time each day to maintain consistent levels of Ledipasvir and Sofosbuvir in your system. You can take this hepatitis C medication with or without food—simply swallow the tablet whole with water. Establishing a routine, such as taking it with breakfast or before bedtime, helps ensure you don't miss doses. Completing the full prescribed course is crucial for successful HCV treatment, even if you feel better. Your doctor will determine whether you need 8, 12, or 24 weeks of therapy based on your specific hepatitis C genotype and liver health status.
Is LediHep 90/400 mg Tablet safe for long-term use?
LediHep 90/400 mg Tablet is designed for finite treatment courses, typically 8 to 24 weeks, rather than indefinite long-term use. This antiviral combination containing Ledipasvir and Sofosbuvir has demonstrated excellent safety profiles during these treatment periods in clinical studies. Once you complete your prescribed course and achieve sustained virologic response, you generally won't need to continue taking this hepatitis C medication. The treatment aims to cure HCV infection permanently, eliminating the need for ongoing therapy. Your healthcare provider will monitor your liver function and viral levels throughout treatment and after completion to confirm successful clearance of the virus.
Can I take LediHep 90/400 mg Tablet with other medicines?
LediHep 90/400 mg Tablet can interact with various medications, so disclosure of all current medicines is essential. This hepatitis C treatment containing Ledipasvir and Sofosbuvir may interact with certain heart medications like amiodarone, acid-reducing drugs including proton pump inhibitors, anticonvulsants, St. John's Wort, and some cholesterol-lowering statins. HIV medications, particularly some antiretrovirals, may also require dose adjustments. The antiviral components can affect how your body processes other drugs. Always inform your healthcare provider about all prescription medicines, over-the-counter products, herbal supplements, and vitamins you're taking before starting this HCV therapy to avoid potentially serious interactions.
How does LediHep 90/400 mg Tablet compare to similar medicines in its class?
LediHep 90/400 mg Tablet, containing Ledipasvir 90mg and Sofosbuvir 400mg, stands among the most effective direct-acting antiviral therapies for hepatitis C. Compared to interferon-based treatments, this combination offers significantly better tolerability with fewer side effects and shorter treatment duration. Against other DAA combinations like Sofosbuvir/Velpatasvir or Glecaprevir/Pibrentasvir, this Ledipasvir-Sofosbuvir formulation shows comparable cure rates exceeding 95% for HCV genotypes 1 and 4. Its once-daily dosing and well-established safety profile make it a preferred choice. The single-tablet regimen simplifies adherence compared to multi-pill hepatitis C treatments, contributing to its clinical success and widespread adoption globally.
Is the generic Ledipasvir 90mg & Sofosbuvir 400mg as effective as branded versions?
Generic versions of Ledipasvir 90mg & Sofosbuvir 400mg, including LediHep 90/400 mg Tablet, deliver the same therapeutic effectiveness as branded formulations like Harvoni. These generic hepatitis C medications contain identical active pharmaceutical ingredients in the same strengths and must meet stringent bioequivalence standards set by regulatory authorities. Clinical outcomes, including sustained virologic response rates and viral clearance, remain equivalent between generic and branded versions. The primary difference lies in cost—generic antivirals typically offer substantial savings while maintaining the same quality, safety, and efficacy. Reputable manufacturers produce these generics under strict quality controls, making them a reliable and affordable option for HCV treatment.
Why do patients choose PremiumRxDrugs for LediHep 90/400 mg Tablet?
Patients choose PremiumRxDrugs for LediHep 90/400 mg Tablet because of guaranteed medication authenticity, competitive pricing on this hepatitis C treatment, and reliable international service. As a licensed pharmacy with more than ten years of experience, we source genuine Ledipasvir 90mg & Sofosbuvir 400mg directly from manufacturers, ensuring quality. Our discreet packaging protects privacy while worldwide shipping with free delivery options makes this antiviral therapy accessible globally across the USA, UK, Australia, and Canada. The platform simplifies prescription management and reordering for ongoing HCV treatment courses. Combined with responsive customer support and transparent pricing, PremiumRxDrugs offers hepatitis C patients a trustworthy, cost-effective alternative for accessing essential medication.
What are the common side effects of Ledipasvir 90mg & Sofosbuvir 400mg?
Common side effects of Ledipasvir 90mg & Sofosbuvir 400mg include fatigue, headache, nausea, and trouble sleeping. Some patients taking this antiviral combination for hepatitis C may experience diarrhea, irritability, or dizziness. Most side effects are mild to moderate and often diminish as your body adjusts to the medication. Less common reactions include rash, muscle aches, or changes in appetite. Serious side effects are rare but may include severe fatigue, unusual bleeding or bruising, or signs of liver problems. The overall tolerability profile of this direct-acting antiviral therapy is excellent compared to older hepatitis C treatments, with most patients completing their full course comfortably.
Who should avoid taking Ledipasvir 90mg & Sofosbuvir 400mg?
Ledipasvir 90mg & Sofosbuvir 400mg should be avoided by individuals with known hypersensitivity to either component of this hepatitis C medication. Patients taking amiodarone for heart rhythm problems face serious risks and generally should not use this antiviral combination due to potential severe bradycardia. Those with severe liver impairment beyond hepatitis C damage may require careful evaluation. Pregnant women should discuss risks versus benefits, as safety data remains limited. If you're taking certain medications including St. John's Wort, rifampin, or specific anticonvulsants, this treatment may not be suitable due to dangerous interactions. Your healthcare provider will assess your complete medical history before prescribing this direct-acting antiviral therapy.
Login
Sign Up
Login
Sign Up